Hainan Shuangcheng Pharmaceuticals Co., Ltd.

Founded in 2000, Shuangcheng Pharma is a publicly-traded company and engaged in R&D, manufacturing and marketing of both peptide APIs and drug products. Having excellent know-how in peptide chemistry, we are a leader in the field of peptide manufacture, with NMPA, U.S.FDA, SFDA (KSA), and TGA approved products on market. We supply peptide APIs and drug products, and also provide tailored CMO/CDMO services. The company is headquartered near Haikou airport on Hainan Free Trade Port. We are rapidly expanding in China and elsewhere around the world, and presently seeking collaborations and partnership with pharmaceutical companies worldwide. Currently, we have 6 ANDAs get USFDA, SFDA (KSA), and TGA approval, 3 ANDAs under USFDA review and also more than 27 drug products in pipeline. In the coming years, Shuangcheng Pharma will continue to submit ANDAs to U.S.FDA. Shuangcheng Pharma has passed several inspections by NMPA and foreign Authorities, including US FDA unannounced inspection, PAI and EMA on-site inspection. All facilities for APIs and different dosage forms (peptide APIs, oral solid dosages, sterile injections and lyophilized formulations) comply with cGMP requirements.